| Amy Baxter, PT, DPT, OCS | |
|
4343 All Seasons Dr Ste 220, Hilliard, OH 43026-1962 | |
| (614) 544-1100 | |
| Not Available |
| Full Name | Amy Baxter |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 4343 All Seasons Dr Ste 220, Hilliard, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083138564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT014511 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Baxter, PT, DPT, OCS 2024 Zollinger Rd, Columbus, OH 43221-1928 Ph: (513) 505-9507 | Amy Baxter, PT, DPT, OCS 4343 All Seasons Dr Ste 220, Hilliard, OH 43026-1962 Ph: (614) 544-1100 |
News Archive
New research from WHO and partners shows that the COVID-19 pandemic is severely affecting the quality of care given to small and sick newborns, resulting in unnecessary suffering and deaths.
A new study, presented today, demonstrates treatment for Hepatitis C can be provided safely and effectively within a community-based and non-specialist setting. This illustrates the potential for alternative providers to ease pressure on currently overburdened specialists. The study, sponsored by the National Institutes of Health, was presented at The International Liver Congress 2016 in Barcelona, Spain.
Computer Sciences Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Vaccinia Immune Globulin (VIGIV), an intravenous immune globulin, to treat rare adverse reactions to smallpox vaccination.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
› Verified 7 days ago
Mrs. Evaine Delaney Crane, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3825 Trueman Ct, Hilliard, OH 43026 Phone: 614-334-1898 Fax: 614-334-2020 | |
Kelly Riggs, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4682 Cemetery Rd, Hilliard, OH 43026 Phone: 614-819-1000 | |
Mrs. Nicole F Kusek, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6048 Woodsview Way, Hilliard, OH 43026 Phone: 614-293-6384 Fax: 614-293-7648 | |
Dr. Erin Elizabeth Brown, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4343 All Seasons Dr, Hilliard, OH 43026 Phone: 614-544-1217 Fax: 614-544-1140 | |
Ati Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3716 Ridge Mill Dr, Hilliard, OH 43026 Phone: 630-296-2223 | |
Ms. Kristin Nicole Welch, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4363 All Seasons Dr, Hilliard, OH 43026 Phone: 614-355-5963 | |
Ben Grover, Physical Therapist Medicare: Medicare Enrolled Practice Location: 4682 Cemetery Rd, Hilliard, OH 43026 Phone: 614-819-1000 |